Comment from The Cure Coalition

Summary: The Cure Coalition, representing patients and health advocates, supports the FDA's effort to modernize drug development and reduce animal testing, provided that patient safety remains the primary priority. They argue that the guidance should be strengthened to ensure that unvalidated new approach methodologies (NAMs) do not replace validated safety testing and that the transition to NAMs must be calibrated to the pace of validated science.